No Data
No Data
IBio Initiated at Buy by Chardan Capital
IBio Initiated at Buy by Chardan Capital
IBio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/28/2024 121.24% Chardan Capital → $5 Initiates Coverage On → Buy 02/16/2023 — JMP Securities Downgrade
Express News | Ibio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $5
Chardan Research Starts IBio With Buy Rating, $5 Price Target
Chardan Research Starts iBio With Buy Rating, $5 Price Target.
Express News | Ibio Inc - Purchase and Sale Agreement Provides That Property Will Be Sold to Board of Regents for a Purchase Price of $8.5 Mln
Express News | Ibio Inc - Ibio CDMO LLC Entered Into Purchase, Sale Agreement, Dated as of May 17, With Board of Regents of Texas a&M University System